GlassScriptPhysician profile
Jane Singer
NPI 1053335778
$1,313.95
in general payments reported to CMS, 2019-2025
16 companies · $243 in 2025
The $243 reported for 2025 was more than what 85% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $442 · 2022: $292 · 2023: $71.57 · 2024: $265 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $579.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $420.22 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $245.37 | 2021-2025 | Annovera, Nextstellis |
| Shield Therapeutics INC | $154.54 | 2022-2025 | |
| Exeltis, USA INC. | $113.99 | 2021-2024 | Slynd |
| Evofem Biosciences, INC. | $82.30 | 2021-2022 | |
| Organon LLC | $65.64 | 2022-2025 | Nexplanon |
| Novo Nordisk INC | $60.69 | 2024-2025 | Wegovy |
| Vivus LLC | $31.21 | 2021-2024 | Qsymia |
| Avion Pharmaceuticals | $26.02 | 2022 | |
| Sumitomo Pharma America, INC. | $23.45 | 2024 | Myfembree |
| Biogen, INC. | $17.63 | 2025 | Zurzuvae |
| Mission Pharmacal Company | $15.84 | 2021-2024 | Citranatal Medley |
| Mimedx Group, INC. | $15.71 | 2024 | |
| Millicent US INC | $14.27 | 2025 | Femring, Intrarosa |
| Currax Pharmaceuticals LLC | $14.14 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $12.93 | 2023 | Twirla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Singer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.